homocysteine-thiolactone-2-chloronicotinamide and Muscle Contraction

homocysteine-thiolactone-2-chloronicotinamide has been researched along with Muscle Contraction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Janković, G; Kostić-Rajačić, S; Rizvić, E; Savić, MM	1

Other Studies

1 other study(ies) available for homocysteine-thiolactone-2-chloronicotinamide and Muscle Contraction

Article	Year
Atypical sympathomimetic drug lerimazoline mediates contractile effects in rat aorta predominantly by 5-HT2A receptors. Bosnian journal of basic medical sciences, 2017, Aug-20, Volume: 17, Issue:3 Topics: Animals; Aorta, Thoracic; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Phenylephrine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Serotonin Antagonists; Sympathomimetics; Vasoconstrictor Agents	2017

Article

Year

Atypical sympathomimetic drug lerimazoline mediates contractile effects in rat aorta predominantly by 5-HT2A receptors.

Bosnian journal of basic medical sciences, 2017, Aug-20, Volume: 17, Issue:3

Topics: Animals; Aorta, Thoracic; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Phenylephrine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Serotonin Antagonists; Sympathomimetics; Vasoconstrictor Agents

2017